Biosim makers scored a big win Monday as the Supreme Court ruled with Sandoz in a much-watched legal dispute against Amgen. The landmark decision, set to leave a distinct mark on the budding field, ...
As challengers to Roche’s cancer blockbusters advance in the U.S. and around the world, Samsung Bioepis has taken a big step toward approval for a Herceptin biosim in Europe. A drug panel there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results